Here are relevant reports on : artificial-intelligence-drug-discovery-market
-
Artificial Intelligence in Retail Market by Solution (Personalized Product Recommendation, Visual Search, Virtual Stores, Virtual Customer Assistant, CRM), Type (Generative AI, Other AI), End-user (Online, Offline) - Global Forecast to 2030
The AI in retail market is projected to reach USD 164.74 billion by 2030, at a CAGR of 32.0% during the forecast period. Microsoft (US), IBM (US), Google (US), Amazon (US), Oracle (US), Salesforce (US), NVIDIA (US), SAP (Germany), ServiceNow (US), Accenture (Ireland), Infosys (India), Alibaba (China), Intel (US), AMD (US), Fujitsu (Japan), Capgemini (France), TCS (India), Talkdesk (US), Symphony AI (US), Bloomreach (US), C3.AI (US), Visenze (Singapore), Pathr.ai (US), Vue.AI (US), Nextail (Spain), Daisy Intelligence (Canada), Cresta (US), Mason (US), Syte (Israel), Trax (Singapore), Feedzai (US), and Shopic (Israel).
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Europe Artificial Intelligence (AI) Market by Infrastructure (Compute, Memory, Networking, Storage), Software (Conversational Assistants, No Code/Low Code, BI & Analytics, Developer Platforms), Technology (ML, NLP, Generative AI) - Forecast to 2032
The Europe AI market size was estimated at USD 86.24 billion in 2025 and is projected to reach USD 548.03 billion by 2032, growing at a CAGR of 30.2% from 2025 to 2032. The major players in the Europe AI market include SAP (Germany), Microsoft (US), IBM (US), Oracle (US), AWS (US), Siemens (Germany), NVIDIA (US), OpenAI (US), Google (US), H2O.ai (US), and Salesforce (US), along with startups/SMEs such as Graphcore (UK), DeepL (Germany), Synthesia (UK), and Gamaya (Switzerland).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Smart Hospital Market by Component (Hardware, Services, and Systems & Software), Services Rendered (General, Specialty, and Super Specialty), Connectivity, Application, Artificial Intelligence, and Region - Global Forecast to 2023
The smart hospital market was valued at USD 13.52 Billion in 2016 and is expected reach USD 63.49 Billion by 2023, at a CAGR of 24.00% from 2017 to 2023. The major players in the smart hospital market are Medtronic (Ireland), Philips (Netherlands), Microsoft (US), GE Healthcare (US) and Qualcomm Life (US), Honeywell Life Care Solutions (US), SAP (Germany), Allscripts (US), Allengers (India), Siemens AG (Germany), and CitiusTech Inc. (US), Infor (US), Athenahealth (US), PhysIQ (US), Diabetizer (Germany), AdhereTech (US), Epic (US), GlucoVista (US), STANLEY Healthcare (US), Cerner Corporation (US), and McKesson (US).
- Published: September 2017
- Price: $ 4950
- TOC Available:
-
Protein Microarrays Market by Offering (Products, Services), Type (Biochips, Microarray Instruments), Application (Clinical, Drug Discovery) - Global Forecast to 2030
The global protein microarrays market, valued at US$0.93 billion in 2024, stood at US$1.00 billion in 2025 and is projected to advance at a resilient CAGR of 12.3% from 2025 to 2030, culminating in a forecasted valuation of US$1.78 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Base Editing Market by Product (Platform, Reagents & Kits, Plasmids), Service (gRNA Design, Cell Line Engineering), Type, Targeted base (Cytosine, Adenine), Application (Drug Discovery, Agriculture, Veterinary), and Region - Global Forecast to 2028
The global base editing market, valued at US$260 million in 2022, stood at US$270 million in 2023 and is projected to advance at a resilient CAGR of 15.2% from 2023 to 2028, culminating in a forecasted valuation of US$549 million by the end of the period.The growth of the base editing market is largely driven by the rising prevalence of genetic diseases, and the increasing recognition of the role of genetic mutations in various diseases has fueled the demand for precise gene editing technologies.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Europe Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030
The Europe Proteomics market, valued at US$9.80 billion in 2024, stood at US$10.55 billion in 2025 and is projected to advance at a resilient CAGR of 12.2% from 2025 to 2030, culminating in a forecasted valuation of US$18.77 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Pipette Calibrators Market by Type (Devices, Software), Channel Type, Method (Gravimetry, Photometry), Application (Research (Drug Discovery), Clinical Diagnostics), End User (Pharmaceutical & Biotechnology), & Region - Global Forecast to 2029
The global pipette calibrators market, valued at US$255 million in 2022, stood at US$286 million in 2023 and is projected to advance at a resilient CAGR of 6.5% from 2023 to 2028, culminating in a forecasted valuation of US$391 million by the end of the period. The growth in this market is attributed to the increasing need for pipettes in research facilities, and growing use of portable handheld calibration devices, and adoption of cloud-based calibration management. However, presence of alternative simple methods or techniques could restrain the growth of this market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Next-generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Service, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2030
The next-generation sequencing market, valued at US$13.95 billion in 2024, stood at US$14.94 billion in 2025 and is projected to advance at a resilient CAGR of 14.6% from 2025 to 2030, culminating in a forecasted valuation of US$29.53 billion by the end of the period. The next-generation sequencing (NGS) market continues to grow steadily. A key driver of this expansion is the clinical adoption of NGS across oncology, rare diseases, reproductive health, and infectious diseases. This trend is also accompanied by lower cost per genome and the launch of higher-throughput benchtop and clinical instruments.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Protein Characterization Market / Protein Identification Market by Instruments (Chromatography, Electrophoresis, Mass Spectrometry), Consumables & Services, Application (Clinical Diagnosis, Drug Discovery), End User (Pharma, Biotech, CROs) & Region - Global Forecast to 2026
The global protein characterization market growth is primed to transition from $12.6 billion in 2021 to $23.9 billion by 2026, showcasing a strong CAGR of 13.7%. Growth in the protein identification market can mainly be attributed to factors such as rising acceptance of personalized medicine, technological advancement and increased drug discovery & development activities.
- Published: September 2021
- Price: $ 4950
- TOC Available:
-
Drug Discovery Technologies Market by Product (Instruments, Reagents, Software), Technology (HTS, NGS, PCR, AI-based, Lab-on-chip), Process (Target Identification, Validation, Lead Optimization), Therapeutic Area (Oncology, CVD) - Global Forecast to 2030
The Drug Discovery Technologies market, valued at US$28.61 billion in 2024, stood at US$30.58 billion in 2025 and is projected to advance at a resilient CAGR of 11.0% from 2025 to 2030, culminating in a forecasted valuation of US$51.51 billion by the end of the period. The growth of the drug discovery technologies market is driven by the broader use of advanced screening platforms and rising demand for biologics, cell and gene therapies, and RNA-based drugs.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
